Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001622627-24-000039
Filing Date
2024-07-11
Accepted
2024-07-11 17:37:40
Documents
2
Group Members
AHARON GILROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.ROSALIND OPPORTUNITIES FUND I L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 rosalind_clrb_13ga6_july.htm SC 13G/A 105598
2 rosalind_clrb_exa.htm EX-99.A BD-DIR-RESOL 3328
  Complete submission text file 0001622627-24-000039.txt   110861
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85798 | Film No.: 241112815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A